Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Allison Jamison"'
Autor:
Samuel S. Gidding, Christie M. Ballantyne, Marina Cuchel, Sarah de Ferranti, Lisa Hudgins, Allison Jamison, Mary P. McGowan, Amy L. Peterson, Robert D. Steiner, Melissa K. Uveges, Yunshu Wang
Publikováno v:
Global Heart, Vol 19, Iss 1, Pp 43-43 (2024)
Homozygous familial hypercholesterolemia (HoFH) is an ultra-rare inherited condition that affects approximately one in 300,000 people. The disorder is characterized by extremely high, life-threatening levels of low-density lipoprotein (LDL) cholester
Externí odkaz:
https://doaj.org/article/d2058999a0ea4372bd20514d6dc45bef
Autor:
Marina Cuchel, Paul C. Lee, Lisa C. Hudgins, P. Barton Duell, Zahid Ahmad, Seth J. Baum, MacRae F. Linton, Sarah D. de Ferranti, Christie M. Ballantyne, John A. Larry, Linda C. Hemphill, Iris Kindt, Samuel S. Gidding, Seth S. Martin, Patrick M. Moriarty, Paul P. Thompson, James A. Underberg, John R. Guyton, Rolf L. Andersen, David J. Whellan, Irwin Benuck, John P. Kane, Kelly Myers, William Howard, David Staszak, Allison Jamison, Mary C. Card, Mafalda Bourbon, Joana R. Chora, Daniel J. Rader, Joshua W. Knowles, Katherine Wilemon, Mary P. McGowan
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 12, Iss 9 (2023)
Background Homozygous familial hypercholesterolemia (HoFH) is a rare, treatment‐resistant disorder characterized by early‐onset atherosclerotic and aortic valvular cardiovascular disease if left untreated. Contemporary information on HoFH in the
Externí odkaz:
https://doaj.org/article/9dcee4a6f1ed4758895b21e17b75e550
Autor:
Claudia Stefanutti, Myra Tilney, Mutaz Alkhnifsawi, Carlos A. Aguilar-Salinas, Jean-Luc Eiselé, Raul D. Santos, Pedro Mata, Gloria Hastings, Gerald F. Watts, Inge Schalkers, Sarah D. de Ferranti, Francesco Fuggetta, Daniel Soffer, Brian Tomlinson, Rodrigo Alonso, Tania Leme da Rocha Martinez, Rody G. Sy, Maria Cristina de Oliveira Izar, Atsushi Nohara, Ákos G Gesztes, Laura Schreier, Nanette K. Wenger, Aram Zegerius, Leiv Ose, Letrillart Marion, David Marais, André R. Miserez, Lina Badimon, Ian Hamilton-Craig, Martin Prøven Bogsrud, Roopa Mehta, Stephen J. Nicholls, Lale Tokgozoglu, Samuel S. Gidding, Amy L. Peterson, Mariko Harada-Shiba, Sue Koob, Jules Payne, Emanuela Folco, Raman Puri, Meral Kayıkçıoğlu, Martha L. Tamayo, Michael D. Shapiro, David S. Wald, Børge G. Nordestgaard, Inese Maurina, Kristyna Cillíková, Antonio J. Vallejo-Vaz, Gerardo Elikir, Masahiro Koseki, Diana Maxwell, Ashraf Reda, Gunnar N Karlsson, Jasmine Patel, Lynne T. Braun, Greizy López, Jing Pang, Marcos M. Lima-Martínez, Urh Groselj, G. Kees Hovingh, Kausik K. Ray, Stacey R. Lane, Eric J.G. Sijbrands, Darien Wood, I.M. Gaspar, Pablo Corral, Alberico L. Catapano, Alejandra Vázquez-Cárdenas, Khalid Al-Rasadi, Luz M Bernal, Allison Jamison, Wael Almahmeed, Catherine D. Ahmed, Joep C. Defesche, Olivier S. Descamps, Tomáš Freiberger, Athanasios Pallidis, Dermot Neely, Gabriele Hanauer-Mader, Tiziana Sampietro, Liam R. Brunham, Patrícia Vieira de Luca, Mario Stoll, Michaela Wolf, Monica P Popescu, Regina Cuevas, Thomas A. Gaziano, George A. Mensah, Katherine Wilemon
Publikováno v:
JAMA Cardiology, 5(2), 217-229. American Medical Association
Wilemon, K A, Patel, J, Aguilar-Salinas, C, Ahmed, C D, Alkhnifsawi, M, Almahmeed, W, Alonso, R, Al-Rasadi, K, Badimon, L, Bernal, L M, Bogsrud, M P, Braun, L T, Brunham, L, Catapano, A L, Čillíková, K, Corral, P, Cuevas, R, Defesche, J C, Descamps, O S, De Ferranti, S, Eiselé, J L, Elikir, G, Folco, E, Freiberger, T, Fuggetta, F, Gaspar, I M, Gesztes, Á G, Grošelj, U, Hamilton-Craig, I, Hanauer-Mader, G, Harada-Shiba, M, Hastings, G, Hovingh, G K, Izar, M C, Jamison, A, Karlsson, G N, Kayikçioǧlu, M, Koob, S, Koseki, M, Lane, S, Lima-Martinez, M M, López, G, Martinez, T L, Marais, D, Marion, L, Mata, P, Maurina, I, Maxwell, D, Mehta, R, Nordestgaard, B G & Global Familial Hypercholesterolemia Community 2020, ' Reducing the Clinical and Public Health Burden of Familial Hypercholesterolemia : A Global Call to Action ', JAMA Cardiology, vol. 5, no. 2, pp. 217-229 . https://doi.org/10.1001/jamacardio.2019.5173
Wilemon, K A, Patel, J, Aguilar-Salinas, C, Ahmed, C D, Alkhnifsawi, M, Almahmeed, W, Alonso, R, Al-Rasadi, K, Badimon, L, Bernal, L M, Bogsrud, M P, Braun, L T, Brunham, L, Catapano, A L, Čillíková, K, Corral, P, Cuevas, R, Defesche, J C, Descamps, O S, De Ferranti, S, Eiselé, J L, Elikir, G, Folco, E, Freiberger, T, Fuggetta, F, Gaspar, I M, Gesztes, Á G, Grošelj, U, Hamilton-Craig, I, Hanauer-Mader, G, Harada-Shiba, M, Hastings, G, Hovingh, G K, Izar, M C, Jamison, A, Karlsson, G N, Kayikçioǧlu, M, Koob, S, Koseki, M, Lane, S, Lima-Martinez, M M, López, G, Martinez, T L, Marais, D, Marion, L, Mata, P, Maurina, I, Maxwell, D, Mehta, R, Nordestgaard, B G & Global Familial Hypercholesterolemia Community 2020, ' Reducing the Clinical and Public Health Burden of Familial Hypercholesterolemia : A Global Call to Action ', JAMA Cardiology, vol. 5, no. 2, pp. 217-229 . https://doi.org/10.1001/jamacardio.2019.5173
ImportanceFamilial hypercholesterolemia (FH) is an underdiagnosed and undertreated genetic disorder that leads to premature morbidity and mortality due to atherosclerotic cardiovascular disease. Familial hypercholesterolemia affects 1 in 200 to 250 p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94f68755387d1d8493ed31ed5cf8c1a0
https://pubmed.ncbi.nlm.nih.gov/32186650
https://pubmed.ncbi.nlm.nih.gov/32186650